New England Journal of Medicine published a clinical update in Research Highlights on 01 Apr 2026. The item focuses on Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer. Review the original article for the full source wording and details.
New England Journal of Medicine published a clinical update in Research Highlights on 01 Apr 2026.
The item focuses on Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer.
Review the original article for the full source wording and details.